Hypothesis: antiplatelet effects of selective serotonin reuptake inhibitors cause clinical benefits on cardiovascular disease and increase risks of bleeding.

Journal Article (Journal Article)

Full Text

Duke Authors

Cited Authors

Serebruany, VL; O'Connor, CM; Krishnan, RR; Hennekens, CH

Published Date

September 2005

Published In

Journal of Cardiovascular Pharmacology and Therapeutics

Volume / Issue

10 / 3

Start / End Page

163 - 164

PubMed ID

16211204

International Standard Serial Number (ISSN)

1074-2484

Digital Object Identifier (DOI)

10.1177/107424840501000303

Language

eng

Conference Location

United States